Jonas Adalsteinn Adalsteinsson MD PhD
Director, Autoimmune Bullous Diseases Director, Dermato-epidemiology
Join to View Full Profile
5 E 98th StFl 5New York, NY 10029
Phone+1 212-241-9728
Fax+1 860-714-8275
Dr. Adalsteinsson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of ConnecticutResidency, Dermatology, 2019 - 2022- University of ConnecticutResidency, Internal Medicine, 2018 - 2019
Icahn School of Medicine at Mount SinaiPost-Doctoral Fellowship, Dermatology, 2017 - 2018
University of IcelandClass of 2016
Certifications & Licensure
NY State Medical License 2023 - 2025
UT State Medical License 2022 - 2024
CT State Medical License 2018 - 2022
American Board of Dermatology Dermatology
Publications & Presentations
PubMed
- Use of Deucravacitinib in Cutaneous Lupus Erythematosus: Two Patient Experiences at a Combined Rheumatology-Dermatology Clinic.Grace M Hren, Isabel Silva, Jonas A Adalsteinsson, Saakshi Khattri
International Journal of Dermatology. 2025-04-25 - Thromboembolism Risk of JAK inhibitors with Concurrent Oral Contraceptive Use: A Global Multicenter Cohort Study.Jasmine Levine, Rahib K Islam, Lillian Mo, Nicholas Gulati, Jonas Adalsteinsson
Clinical and Experimental Dermatology. 2025-04-23 - A postpandemic surge of thick melanomas in women: A nationwide study on skin cancer incidence during COVID-19.Areeba Ahmed, Omar Alani, Eydís Lilja Haraldsdóttir, David Hoyt, Sierra Thomas
Journal of the American Academy of Dermatology. 2025-04-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
